<i>ZMYND11::MBTD1</i> Fusion in Myeloid/NK Cell Precursor Leukemia: A Case Report With Literature Review and Diagnostic Implications
Myeloid/NK cell precursor leukemia (MNKPL) is a rare, aggressive entity often misdiagnosed as acute myeloid leukemia (AML) or aggressive NK cell leukemia (ANKL) because of overlapping markers (CD7<sup>+</sup>, CD13/CD33<sup>+</sup>, CD56<sup>+</sup>, myeloperoxidase [MPO]-). We report a patient initially diagnosed with ANKL; subsequent flow-cytometric reevaluation (CD7<sup>+</sup>, CD13<sup>+</sup>, CD33<sup>+</sup>, CD34<sup>+</sup>, CD56<sup>+</sup>, CD117<sup>+</sup>, MPO<sup>-</sup>) supported a diagnosis of MNKPL. RNA sequencing and nested PCR identified an in-frame ZMYND11::MBTD1 fusion. A review of published ZMYND11::MBTD1 leukemias (n = 5) found immunophenotypes highly consistent with MNKPL, suggesting prior misclassification. These findings support ZMYND11::MBTD1 as a recurrent lesion in MNKPL and a practical aid to diagnosis and treatment selection.
Authors
- Shaoyan Hu
- Shengbin Zhao
- Xin Su (ORCID: https://orcid.org/0000-0002-6629-9856)
- Shengqin Cheng
- Hao Liang
- Zhizhuo Du
- Ping Chen
- Li Gao
- Peifang Xiao
- Jie Miao
Institutions
- Soochow University (CN)
- Suzhou Vocational Health College (CN)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1002/1545-5017.70044
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Brigham and Women's Hospital
- Jiangsu Commission of Health
- Soochow University